The Corporate Strategy team at Delix Therapeutics is responsible for driving the company's long-term vision and growth initiatives. This includes market analysis, competitive intelligence, strategic partnerships, and guiding the company's preclinical and clinical development programs. The team ensures alignment between scientific advancements and business objectives to achieve the goal of alleviating mental suffering with safe, non-hallucinogenic psychoplastogen compounds.
View all